Nephrology and Renal Transplantation Department, AP-HP, Hôpital Henri Mondor, Créteil, France.
UPEC, Université Paris-Est, Créteil, France.
Transpl Int. 2018 Apr;31(4):377-385. doi: 10.1111/tri.13078. Epub 2017 Oct 12.
Solid organ transplantation societies recommend a relative contraindication of transplantation for people with bipolar or psychotic disorders. Very few data are available on the outcome of kidney transplantation and the increased risk of kidney disease in those patients. We conducted a retrospective multicenter cohort study (1979-2014) including kidney allograft recipients with either bipolar (BD) or psychotic disorders prior to transplant. Objectives were kidney allograft and patient outcomes compared to a matched control group without psychiatric disorders and the evolution of psychiatric disorder at 60 months after transplantation. Forty-seven patients including 25 women were identified, 34 with BD and 13 with psychotic disorder. Patients' overall cumulative death rates at 60 months were not significantly different in both groups [12.2%; 95% confidence interval: (4.5-24.1) in the group with psychiatric disorder versus 5.2%; (1.7-11.7) in control group P = 0.11] as for cumulative allograft loss rates [11.7% (3.5-25.2) vs. 9.4% (4.4-16.8) in control group (P = 0.91)]. Twenty-three patients (16 with BD and seven with psychotic disorder) experienced at least one psychiatric relapse [incidence rate: 1.8/100 persons- months; 95% CI; (1.2-2.7)] totaling 13 hospitalizations within 60 months of follow-up. Four patients stopped immunosuppressive therapy leading to allograft loss in three. Our study suggests that patients with BD or psychotic disorders have to be considered for renal transplantation with close psychiatric follow-up after transplant.
实体器官移植学会建议,对于患有双相情感障碍或精神病的患者,相对禁忌进行移植。关于这些患者的肾移植结局和肾脏疾病风险增加的相关数据非常有限。我们进行了一项回顾性多中心队列研究(1979-2014 年),纳入了移植前患有双相情感障碍(BD)或精神病的肾移植受者。研究目的是比较这些患者的肾移植和患者结局与无精神疾病的匹配对照组,以及在移植后 60 个月时精神疾病的演变情况。共确定了 47 例患者,包括 25 名女性,其中 34 例为 BD,13 例为精神病。两组患者在 60 个月时的总累积死亡率没有显著差异[精神病组为 12.2%(95%置信区间:4.5-24.1),对照组为 5.2%(1.7-11.7),P=0.11],累积移植物丢失率也无显著差异[精神病组为 11.7%(3.5-25.2),对照组为 9.4%(4.4-16.8),P=0.91]。23 例患者(16 例为 BD,7 例为精神病)至少经历过一次精神病复发[发生率为 1.8/100 人-月;95%可信区间为(1.2-2.7)],随访 60 个月内共发生 13 次住院治疗。4 例患者停止免疫抑制治疗,导致 3 例移植物丢失。本研究表明,对于患有双相情感障碍或精神病的患者,应考虑进行肾移植,并在移植后进行密切的精神科随访。